📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: BioFlyte

1.1 - Company Overview

BioFlyte Logo

BioFlyte

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biodefense solutions including BioTOF™ z200, a MALDI time-of-flight mass spectrometer for automatic collection and analysis of aerosol samples to detect biological and chemical threats in critical infrastructure; MailScreen™ z200, a mailroom workstation integrating BioTOF™ z200 for detecting hazardous biological powders in mail and parcels; and layered infrastructure protection with aerosol collection, automated handling, and AI/ML analysis.

Products and services

  • BioTOF™ z200: An industrial-grade MALDI time-of-flight mass spectrometer that automatically collects and analyzes aerosol samples for biological and chemical threats in critical infrastructure environments
  • Layered Infrastructure Protection: An AI-enabled technology system incorporating aerosol sample collection, automated handling, and AI/ML analysis to detect and identify biological and pharmaceutical-based aerosol threats
  • MailScreen™ z200: A modular mailroom workstation that integrates BioTOF™ z200 to detect hazardous biological powders in mail and parcels, delivering a comprehensive threat detection product

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to BioFlyte

Accuri Cytometers Logo

Accuri Cytometers

HQ: United States Website
  • Description: Provider of cost-effective flow cytometers for laboratory use, designed to deliver rapid cell-by-cell analysis while reducing barriers for researchers, including instrument cost, software complexity, and maintenance effort.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Accuri Cytometers company profile →
BrightSpec Logo

BrightSpec

HQ: United States Website
  • Description: Provider of analytical chemistry solutions using FT‑MRR and molecular rotational resonance spectroscopy for detailed molecular structure insights. Delivers quantum simulation software to predict and confirm rotational spectra, ultra‑high‑resolution measurements for precise identification and quantitation in complex mixtures, and rapid targeted analysis without front‑end separation for pharmaceutical and chemical applications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BrightSpec company profile →
Phenocell Logo

Phenocell

HQ: France Website
  • Description: Provider of iPSC-derived cell models and R&D outsourcing for pharmaceutical, drug discovery, ophthalmology, dermatology, and dermo-cosmetic applications, including retinal pigment epithelial cells for retinal disorder research, a Dry AMD drug discovery platform, sebocytes for acne/hyperseborrhea, melanocytes for pigmentation, and high-throughput screening and custom bioassays with high genomic stability and reproducibility.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Phenocell company profile →
3D Bio-Tissues Logo

3D Bio-Tissues

HQ: United Kingdom Website
  • Description: Provider of bio-equivalent tissues for clinical and cellular agriculture, including 3DBT corneas engineered to match human donor corneas, Tissue Templating Technology for structured, scalable tissues without animal components, City-Mix culture media supplement to enhance cell performance, and Etsyl, a lipopeptide that stimulates collagen production for cosmetic and pharmacological use.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 3D Bio-Tissues company profile →
Araris Biotech Logo

Araris Biotech

HQ: Switzerland Website
  • Description: Provider of proprietary peptide linker technology for efficient payload attachment without antibody engineering, enabling creation of stable, homogenous, highly soluble antibody-drug conjugates (ADCs) with improved therapeutic efficacy and reduced side effects; also offers ADC development using off-the-shelf antibodies to deliver drugs to cancer cells with improved stability and solubility in a cost-effective manner.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Araris Biotech company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for BioFlyte

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to BioFlyte

2.2 - Growth funds investing in similar companies to BioFlyte

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for BioFlyte

4.2 - Public trading comparable groups for BioFlyte

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to BioFlyte

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About BioFlyte

What does BioFlyte do?

BioFlyte is a provider of biodefense solutions including BioTOF™ z200, a MALDI time-of-flight mass spectrometer for automatic collection and analysis of aerosol samples to detect biological and chemical threats in critical infrastructure; MailScreen™ z200, a mailroom workstation integrating BioTOF™ z200 for detecting hazardous biological powders in mail and parcels; and layered infrastructure protection with aerosol collection, automated handling, and AI/ML analysis.

Who are BioFlyte's competitors?

BioFlyte's competitors and similar companies include Accuri Cytometers, BrightSpec, Phenocell, 3D Bio-Tissues, and Araris Biotech.

Where is BioFlyte headquartered?

BioFlyte is headquartered in United States.

How many employees does BioFlyte have?

BioFlyte has 1,000 employees 🔒.

When was BioFlyte founded?

BioFlyte was founded in 2010 🔒.

What sector and industry vertical is BioFlyte in?

BioFlyte is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for BioFlyte

Who are the top strategic acquirers in BioFlyte's sector and industry

Top strategic M&A buyers and acquirers in BioFlyte's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for BioFlyte?

Top strategic M&A buyers groups and sectors for BioFlyte include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in BioFlyte's sector and industry vertical

Which are the top PE firms investing in BioFlyte's sector and industry vertical?

Top PE firms investing in BioFlyte's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in BioFlyte's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in BioFlyte's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in BioFlyte's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to BioFlyte include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in BioFlyte's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for BioFlyte?

The key public trading comparables and valuation benchmarks for BioFlyte include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for BioFlyte for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for BioFlyte with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in BioFlyte's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for BioFlyte with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in BioFlyte's' sector and industry vertical?

Access recent funding rounds and capital raises in BioFlyte's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for BioFlyte